Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New test could speed up deadly fungus diagnosis in ICU patients

NCT ID NCT03469401

Diagnosis Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested whether measuring a substance called BD glucan in the abdominal fluid of ICU patients with peritonitis can diagnose fungal infections faster than standard lab cultures. Fungal peritonitis is deadly, and current tests take at least 48 hours. The study enrolled 126 adults in intensive care to compare the new test's accuracy against traditional methods.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
BD glucan detection test (Fungitell)
What this could lead to
If successful, this could lead to faster diagnosis of fungal peritonitis, allowing earlier treatment and potentially reducing deaths.
What could go wrong
This is a completed diagnostic study, not a treatment trial. The test may not be accurate enough to replace current methods, and results may not apply to all ICU patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

126 people

The number who actually took part.

Started

Jan 2018

Finished

Feb 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patient (over 18 yr-old) admitted to the ICU for acute peritonitis

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged ≥ 18 years old * written informed consent for inclusion in the study * stay in intensive care unit * diagnosed with a peritonitis * peritoneal fluid collected by a surgery or radiology procedure, analysed at bacteriology laboratory of l'institut des agents infectieux, l'hôpital de la Croix Rousse Exclusion Criteria: * Pregnant woman * Moribund patient

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adult patient (over 18 yr-old) admitted to the icu for acute peritonitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

infectious peritonitis peritonitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adult patient (over 18 yr-old) admitted to the icu for acute peritonitis

Contacts and locations

Locations

  • Centre Hospitalier Lyon Sud

    Pierre-Bénite, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.